Atlas Trials

A Study in Patients With Mild or Moderate Ulcerative Colitis Who Take a TNF Inhibitor. The Study Investigates Whether Bowel Inflammation Improves When Patients Take BI 655130 in Addition to Their Current Therapy

Clinical trial NCT03123120 · COMPLETED

Trial details

NCT number
NCT03123120
Sponsor
Boehringer Ingelheim
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Colitis, Ulcerative
Start date
2017-06-07
Primary completion
2020-03-26
Enrollment
22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.